MANG YA VANG: Open Payments
NPI 1912557786 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 15 payments from 9 companies in 2025. Trend: 2023 $80 · 2024 $115 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $147 |
| Novo Nordisk Inc | 1 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| SK Life Science, Inc. | 1 | $34 |
| Exact Sciences Corporation | 1 | $19 |
| SHIELD THERAPEUTICS INC | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: Wegovy, QULIPTA, UBRELVY, JARDIANCE, Cologuard Collection Kit, ACCRUFER, MOUNJARO, VARIVAX.
Industry payments across TX — which companies pay providers there.
